Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Na+/K+ ATPase β4 Inhibitors

Chemical inhibitors of Na+/K+ ATPase β4 include a range of compounds, most notably cardiac glycosides, which exert their inhibitory effects through binding to the α-subunit of Na+/K+ ATPase. Ouabain, Digoxin, and Digitoxin are classic examples of such inhibitors, each sharing a similar mechanism of action. These chemicals bind with high affinity to the extracellular domain of the α-subunit, which is essential for the enzyme's ion pumping function. This binding alters the conformation of the α-subunit, leading to a cessation of its activity. Since the α and β subunits of Na+/K+ ATPase function as a tightly integrated complex, the inhibition of the α-subunit by these glycosides extends to the β4 subunit, preventing it from performing its regulatory and structural roles in ion transport across cell membranes.

Other chemicals like Bufalin, Peruvoside, and Marinobufagenin, which are also cardiotonic steroids, follow a similar inhibition pathway. By binding to the α-subunit of the enzyme, they disrupt the normal function of Na+/K+ ATPase as a whole, which includes the participation of the β4 subunit. The β4 subunit is crucial for the stability and proper assembly of the Na+/K+ ATPase complex, and its inhibition can be consequential to the enzyme's overall activity. Telocinobufagin and Oleandrin add to this list of inhibitors, with each causing an indirect inhibitory effect on Na+/K+ ATPase β4 by their interaction with the α-subunit. Cinobufagin, with its cardiotonic properties, similarly inhibits the enzyme by targeting the α-subunit, leading to an implied inhibition of the β4 subunit. Besides these, compounds like Rozanolixizumab and Echistatin, although not directly interacting with Na+/K+ ATPase, still can inhibit the β4 subunit by altering the cellular environment in which it operates. Rozanolixizumab, by inhibiting FcRn, can affect the stability and regulation of the β4 subunit, while Echistatin can influence Na+/K+ ATPase activity indirectly by inhibiting integrins, which have been shown to interact with Na+/K+ ATPase in cellular signaling and adhesion processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ouabain-d3 (Major)

sc-478417
1 mg
$516.00
(0)

Ouabain is a cardiac glycoside that specifically inhibits Na+/K+ ATPase by binding to the extracellular domain of the α-subunit, which could lead to an indirect inhibition of the β4 subunit due to the interdependence of the subunits for enzymatic activity.

12β-Hydroxydigitoxin

20830-75-5sc-213604
sc-213604A
1 g
5 g
$143.00
$694.00
(0)

12β-Hydroxydigitoxin, another cardiac glycoside, binds to the α-subunit of Na+/K+ ATPase with high affinity, thereby inhibiting its ion pumping function. This inhibition can extend to the β4 subunit, preventing its normal role in ion transport and regulation.

Digitoxin

71-63-6sc-207577
sc-207577A
sc-207577B
sc-207577C
sc-207577D
250 mg
500 mg
1 g
5 g
10 g
$112.00
$186.00
$319.00
$1102.00
$2040.00
2
(1)

Digitoxin is a cardiac glycoside that inhibits the Na+/K+ ATPase by binding to its α-subunit. Due to the α-β subunit complex formation that is necessary for activity, inhibition of the α-subunit also inhibits the β4 subunit function.

Bufalin

465-21-4sc-200136
sc-200136A
sc-200136B
sc-200136C
10 mg
25 mg
50 mg
100 mg
$99.00
$204.00
$341.00
$544.00
5
(1)

Bufalin is a cardiotonic steroid that exhibits strong inhibitory effects on Na+/K+ ATPase by binding to the α-subunit, which leads to an indirect inhibition of the β4 subunit's functionality as part of the enzyme complex.